Telehealth coaching to improve life quality for pancreatic cancer survivors and their caregivers
Impacting Quality of Life and Pancreatic Cancer Survivorship Through a Telehealth Intervention
This study tests whether telehealth coaching can help improve the quality of life for people surviving pancreatic cancer and their caregivers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 136 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | City of Hope Medical Center Academic / other |
| Locations | 22 sites (Arcadia, California and 21 other locations) |
| Trial ID | NCT06524973 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of telehealth self-management coaching sessions aimed at enhancing the quality of life for survivors of metastatic pancreatic adenocarcinoma and their family caregivers. The program addresses various aspects of well-being, including physical, emotional, social, and spiritual health, which are often compromised due to the disease and its treatment. By providing support through telemedicine, the study seeks to meet the unmet needs of patients and their families during a challenging time. Participants will engage in counseling and complete questionnaires to assess the impact of the intervention.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a confirmed diagnosis of metastatic pancreatic adenocarcinoma within 8 weeks of initial diagnosis, as well as their family caregivers.
Not a fit: Patients who are not diagnosed with metastatic pancreatic adenocarcinoma or those who cannot participate in telehealth sessions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life for pancreatic cancer survivors and their caregivers.
How similar studies have performed: While the specific approach of telehealth self-management coaching for this population may be novel, similar interventions have shown promise in improving quality of life in other cancer patient populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* • PATIENT: Documented informed consent of the participant and/or legally authorized representative
* Assent, when appropriate, will be obtained per institutional guidelines
* PATIENT: Age: ≥ 18 years
* PATIENT: Eastern Cooperative Oncology Group (ECOG) ≤ 2
* PATIENT: Ability to read and understand English or Spanish for questionnaires
* PATIENT: Subjects must have histologically or cytologically confirmed diagnosis of metastatic pancreatic adenocarcinoma who are within 8 weeks of initial diagnosis
* FAMILY CARE GIVER: Documented informed consent of the participant and/or legally authorized representative
* Assent, when appropriate, will be obtained per institutional guidelines
* FAMILY CARE GIVER: Age: ≥ 18 years
* FAMILY CARE GIVER: Ability to read and understand English or Spanish for questionnaires
* FAMILY CARE GIVER: A family member or friend identified by the patient and defined as a person who knows the patient well and is involved in the patient's medical care
Exclusion Criteria:
* • An employee who is under the direct/ indirect supervision of the principal investigator (PI)/ a co-investigator/ the study manager
* A direct study team member
Where this trial is running
Arcadia, California and 21 other locations
- City of Hope at Arcadia — Arcadia, California, United States (Not_yet_recruiting)
- City of Hope Corona — Corona, California, United States (Not_yet_recruiting)
- City of Hope at Duarte — Duarte, California, United States (Recruiting)
- City of Hope Comprehensive Cancer Center — Duarte, California, United States (Not_yet_recruiting)
- City of Hope at Glendale — Glendale, California, United States (Not_yet_recruiting)
- City of Hope at Glendora — Glendora, California, United States (Not_yet_recruiting)
- City of Hope Seacliff — Huntington Beach, California, United States (Not_yet_recruiting)
- City of Hope at Irvine Lennar — Irvine, California, United States (Not_yet_recruiting)
- City of Hope at Irvine Sand Canyon — Irvine, California, United States (Not_yet_recruiting)
- City of Hope Antelope Valley — Lancaster, California, United States (Not_yet_recruiting)
- City of Hope at Long Beach Worsham — Long Beach, California, United States (Not_yet_recruiting)
- City of Hope at Long Beach Elm — Long Beach, California, United States (Not_yet_recruiting)
- City of Hope Mission Hills — Mission Hills, California, United States (Not_yet_recruiting)
- City of Hope at Newport Beach Fashion Island — Newport Beach, California, United States (Not_yet_recruiting)
- City of Hope at Palmdale — Palmdale, California, United States (Not_yet_recruiting)
- City of Hope - Santa Clarita — Santa Clarita, California, United States (Not_yet_recruiting)
- City of Hope at Simi Valley — Simi Valley, California, United States (Not_yet_recruiting)
- City of Hope South Pasadena — South Pasadena, California, United States (Not_yet_recruiting)
- City of Hope at Thousand Oaks — Thousand Oaks, California, United States (Not_yet_recruiting)
- City of Hope South Bay — Torrance, California, United States (Not_yet_recruiting)
- City of Hope Upland — Upland, California, United States (Not_yet_recruiting)
- City of Hope West Covina — West Covina, California, United States (Not_yet_recruiting)
Study contacts
- Principal investigator: Vincent Chung, MD — City of Hope Medical Center
- Study coordinator: Vincent Chung, MD
- Email: vchung@coh.org
- Phone: 626-359-8111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.